The company was established in 2018 in Kayseri/Turkey by academic staff with the techno-entrepreneurship capital support program (BiGG) and started the mass production and sales process of its first products. The company produces the antibodies required for rapid diagnostic kits used in the diagnosis of disease agents and realizes the rapid diagnostic kit and mass production processes.
Rapid diagnostic kits are currently used as "chairside/point-of-care rapid diagnostic kits" in areas such as pregnancy, infection, AIDS, tumor, heart attack, chemical / toxic residue. According to the results of market analysis, the world rapid diagnostic kit market is growing every year and it is predicted that the size of the market will reach a volume of 8.24 billion dollars for 2022, and veterinary diagnostic kits will have a share of 760 million dollars in this volume.
The company is currently mass-producing a quadruple diagnostic kit that can simultaneously recognize four different factors in calf diarrhea. The rapid diagnosis kit, which recognizes canine parvovirus and canine coronavirus factors of dogs, is in the final quality control phase and will come to the mass production stage in a few months. It is at the point of starting the final stage of product development for distemper and adenovirus disease factors of dogs, and it is aimed to introduce products to the market in the third quarter of 2021.
In addition to the founders, a veterinarian and 2 laboratories work in the R&D center, which is located in Erciyes Teknopark A.Ş. The company has an annual production capacity of 100 thousand products. The company has ISO9001, ISO 13485 quality management system certificates. The target audience/market of its products is veterinarians or veterinary animal hospitals.
The company is looking for a distribution service agreement to cooperate and make agreements with companies that sell and market similar kits.
Advantages & innovations
- The most prominent advantage of the company is its ability to develop and produce antigen-specific antibodies, which are the most indispensable part of diagnostic kits
- The company carries out its production under international standards (ISO9001, ISO 13485)
- In addition, it can be offered with advantages such as product lead time and low price
- the firm has an academic staff
Stage of development
Already on the market
Partner sought
The company wants to work with companies operating in the development, production, sales, and marketing of veterinary diagnostic kits. The expectation of the company is to ensure that the products can be marketed in different countries.
Potential collaborators are expected to sell and support the company's products in the domestic or international market via a distribution service.